Post ASH 2022: High-grade B-cell Lymphomas, what’s new?

Review Article

Haema 2023; 14(1-4):34-38

Pineopi Vryttia, Sotirios G. Papageorgiou

Second Department of Internal Medicine and Research Institute, Hematology Unit, Attikon University General Hospital

 

Full PDF |

Continue reading “Post ASH 2022: High-grade B-cell Lymphomas, what’s new?”

Post ASH 2022: Hemoglobinopathies

Review Article

Haema 2023; 14(1-4):39-42

Theodora-Maria Venou1, Efthimia Vlachaki2

1Second Chemotherapy Department, Theagenio Anticancer Hospital, Thessaloniki, Greece
2Adult Thalassemia Unit, Second Department of Internal Medicine, Aristotle University, Hippokration Hospital, Thessaloniki, Greece

 

Full PDF |

Continue reading “Post ASH 2022: Hemoglobinopathies”

Post ASH 2022: Acute Myeloid Leukemia

Review Article

Haema 2023; 14(1-4):6-10

Michael D. Diamantidis1, George Vassilopoulos2

1Thalassemia and Sickle Cell Disease Unit, Department of Hematology, General Hospital of Larissa, Larissa, Greece,
2University of Thessaly Medical School, Head, Division of Hematology, Larisa University Hospital, Affiliate Investigator, Cell and Gene Therapy Lab, BRFAA Athens, Greece

 

Full PDF |

Continue reading “Post ASH 2022: Acute Myeloid Leukemia”

Prognostic Significance of IDH1 and IDH2 Mutations in Greek Patients with Newly Diagnosed AML

Original Article

Haema 2022; 13(1-2):31-42

Aikaterini Bitsani, Anna Efthymiou, Maria Roumelioti, Eftychia Staikou, Aggeliki Stefanou, Danai Palaiologou, Georgios Georgiou, Georgios Boutsikas, Maria-Christina Kyrtsonis, Panayiotis Panayiotidis

Hematology section, First Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens Medical School, Greece

Full PDF |

Continue reading “Prognostic Significance of IDH1 and IDH2 Mutations in Greek Patients with Newly Diagnosed AML”

The Role of Venetoclax in the Treatment of Acute Myeloid Leukemia

Review Article

Haema 2022; 13(1-2):20-30

Maria Dimou

Hematology Clinical Trial Unit, Hematology and Bone Marrow Transplantation Clinic, National and Kapodistrian University of Athens, Greece

Full PDF |

Continue reading “The Role of Venetoclax in the Treatment of Acute Myeloid Leukemia”

Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies

Review Article

Haema 2022; 13(1-2):14-19

Athanasios Liaskas1, Fotios Panitsas1, Evrydiki Kravvariti2, Maria K. Angelopoulou1, Gerassimos A. Pangalis3, Theodoros P. Vassilakopoulos1

1Department of Haematology,
2First Department of Propaedeutic Internal Medicine, Joint Rheumatology Academic Program,
3Department of Haematology, Athens Medical Center, Psychikon Branch, Athens,Greece

Full PDF |

Continue reading “Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies”

Differential Diagnosis of Thrombotic Microangiopathies: From Bench to Bedside

Review Article

Haema 2022; 13(1-2):4-13

Eleni Gavriilaki, Ioanna Sakellari, Achilles Anagnostopoulos

Hematology Department – BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Full PDF |

Continue reading “Differential Diagnosis of Thrombotic Microangiopathies: From Bench to Bedside”

Comment on: Bitsani et al “Prognostic Significance of IDH1 and IDH2 Mutations in Newly Diagnosed AML Patients in Greece”

Editorial

Haema 2022; 13(1-2):1-3

Emmanouil Nikolousis

MD, PhD, FRCP, FRCPath, MBA, Associate Professor European University of Cyprus, Clinical Director of Haematology Athens Medical Centre

Full PDF |

Continue reading “Comment on: Bitsani et al “Prognostic Significance of IDH1 and IDH2 Mutations in Newly Diagnosed AML Patients in Greece””